- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Childhood Sexual Abuse Litigation
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Restructuring and Business Bankruptcy
- Wealth Planning, Administration, and Disputes
- Litigation Support Services
-
December 4, 2019State of Minnesota Sues JUUL
-
November 26, 2019Minnesota Lawyer Honors Two Robins Kaplan Attorneys as 2019 Attorneys of the Year
-
November 21, 2019Firm, Attorney Stacey Slaughter Recognized by National Law Journal
-
January 10, 2020Bridgeport 2020 Consumer Class Action Litigation Conference
-
January 15-17, 2020Loss Executives Association 89th Annual Meeting and Mid-Winter Educational Program
-
January 28, 2020Boston 1L Diversity Summer Associate Program Reception
-
November 2019CLASS ACTION: Experts weigh in on significant class action developments
-
November 15, 20192019 Case Developments: Are Massachusetts Insurers Required To Be Perfect In An Imperfect World?
-
November 15, 2019Artificial Intelligence v. General Data Protection Regulation: Complex Risks in Changing Times
Stryker Orthopedics Recalls its Rejuvenate and ABG II Modular Neck Hip Stems
You must read the following notice before sending an e-mail message to Robins Kaplan LLP.
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
Defective Hip Implants by Stryker® Orthopedics
Some hip implants are designed in two pieces—the stem and the neck. This type of design is called a modular design and can enable more flexibility during surgery. Unfortunately, this two-piece design can also cause serious problems including the release of metal ions into surrounding tissue, pain, necrosis (death of cells), and the need for complex revision surgery. As a result, on July 6, 2012, Stryker® Orthopedics recalled two of their hip replacement products, Rejuvenate® and ABG™II. All global production and sales of these products was stopped.
Update: Global Resolution Reached in Lawsuits over Stryker Rejuvenate/ABG II Failed Hips
On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABG II modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. The settlement was finalized after four months of negotiations before retired United States Magistrate Judge Diane Welsh of JAMS in Philadelphia. Stryker and plaintiffs’ counsel appointed by Judge Martinotti – Ellen Relkin of Weitz & Luxenberg, NYC; Cal Warriner of Searcy Denney, West Palm Beach, FL; Thomas R. Anapol of Anapol Schwartz, Philadelphia; and Tara Sutton of Minneapolis-based Robins Kaplan LLP - reached agreement on behalf of an estimated 3,000 patients who were implanted with the modular Rejuvenate or ABG II implants and have undergone a revision surgery. Counsel from the parallel federal Multi-District Litigation proceedings in Minnesota subsequently joined the negotiations and are signatories to the Agreement. Tobias Millrood and David Buchanan, the other members of the NJ PSC, played key roles advancing the discovery and bellwether trial process serving as a catalyst to the settlement.
Do you have a Stryker Rejuvenate® or ABG™II Modular Implant?
At Robins Kaplan LLP, we investigate potential claims on behalf of defective hip replacement patients to see if they may have a defective hip replacement lawsuit. Our firm has several attorneys experienced in Stryker hip replacement cases. We are among the first in the country to achieve a settlement in a Stryker hip replacement case.
We are careful listeners and your story is important to us. Our on-staff legal nurse consultants are available to answer your questions and listen to your concerns as you determine what to do next.
For a free case evaluation, please call 1.800.553.9910 (toll-free) or fill out the form. Our legal nurse consultants are standing by.
Learn more about defective Stryker Hip Implants >
If you or someone you know has had Rejuvenate® or ABGII ™ implants and are experiencing problems or pain, you may have a Stryker Orthopedics claim or lawsuit. Please call 1.800.553.9910. Our dedicated team of attorneys is experienced in handling defective hip implant lawsuits.
© 2014 Robins Kaplan LLP
RELATED PROFESSIONALS
Tara D. Sutton
Partner
Holly H. Dolejsi
Principal
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.